Jupiter Research Capital (Asia) Ltd’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
Other funds holding MYGN
Jupiter Research Capital (Asia) Ltd's MYGN Position: Q3 2026 in Review
Jupiter Research Capital (Asia) Ltd opened a new position in Myriad Genetics (MYGN) in Q3 2026: 31,320 shares worth $135K. The stake represents 0.01% of the portfolio and ranks #639 among its holdings. This is a return to the name: Jupiter Research Capital (Asia) Ltd previously reported a position in MYGN as recently as Q1 2026.
Jupiter Research Capital (Asia) Ltd first reported a position in MYGN in Q1 2026 and has held it in 2 quarters since. The position peaked at $559K in Q1 2026. 170 funds tracked by Wall St. Rank hold MYGN as of Q3 2026.
- Jupiter Research Capital (Asia) Ltd held 31,320 shares of Myriad Genetics worth $135K as of Q3 2026.
- Myriad Genetics was a new Jupiter Research Capital (Asia) Ltd position in Q3 2026.
- Myriad Genetics made up 0.01% of Jupiter Research Capital (Asia) Ltd's portfolio in Q3 2026, its #639 holding.
- Jupiter Research Capital (Asia) Ltd first reported a position in Myriad Genetics in Q1 2026 and has held it in 2 quarters since.
- Jupiter Research Capital (Asia) Ltd's Myriad Genetics position peaked at $559K in Q1 2026.
- 170 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2026.
Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q3 2026, filed 16 Nov 2026.